Filtered By:
Specialty: Neurology
Condition: Bleeding
This page shows you your search results in order of date. This is page number 11.
Order by Relevance | Date
Total 720 results found since Jan 2013.
Hospital admissions of acute cerebrovascular diseases during and after the first wave of the COVID-19 pandemic: a state-wide experience from Austria
AbstractWe investigated hospital admission rates for the entire spectrum of acute cerebrovascular diseases and of recanalization treatments for ischaemic stroke (IS) in the Austrian federal state of Styria during and also after the first coronavirus disease 2019 (COVID-19) wave. We retrospectively identified all patients with transient ischaemic attack (TIA), IS and non-traumatic intracranial haemorrhage (ICH; including intracerebral, subdural and subarachnoid bleeding types) admitted to one of the 11 public hospitals in Styria (covering > 95% of inhospital cerebrovascular events in this region). Information was e...
Source: Journal of Neurology - September 27, 2021 Category: Neurology Source Type: research
Dual-Antiplatelet Therapy May Not Be Associated With an Increased Risk of In-hospital Bleeding in Patients With Moderate or Severe Ischemic Stroke
Conclusions: In this single center cohort, symptomatic ICH and the composite of serious systemic bleeding and symptomatic ICH was rare in patients on DAPT. Relative to single antiplatelet therapy DAPT was not associated with an increased risk of in-hospital bleeding in patients with moderate and severe ischemic stroke.
Source: Frontiers in Neurology - September 20, 2021 Category: Neurology Source Type: research
Ticagrelor of Net Clinical Benefit After Stroke, TIA: THALES Ticagrelor of Net Clinical Benefit After Stroke, TIA: THALES
A new analysis of data from the THALES trial separates out the reduction in ischemic events from the increase in bleeding events and shows the benefit outweighs the risk in a ratio of four-to-one.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - September 17, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Sedation Mode During Endovascular Stroke Treatment in the Posterior Circulation —Is Conscious Sedation for Eligible Patients Feasible?
Conclusions: In this retrospective study, EST of the posterior circulation under conscious sedation was for eligible patients comparably safe and effective to patients treated under general anesthesia.
Source: Frontiers in Neurology - September 17, 2021 Category: Neurology Source Type: research
Aspirin and Heparin Increase Bleeding Risk During EVT Aspirin and Heparin Increase Bleeding Risk During EVT
New data from MR CLEAN-MED show that aspirin and heparin, alone or in combination, double the risk for symptomatic intracranial hemorrhage when given during endovascular therapy (EVT) for ischemic stroke.Medscape Medical News
Source: Medscape Neurology and Neurosurgery Headlines - September 15, 2021 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
Stroke in Patients with Left Ventricular Assist Devices
Background: Left ventricular assist devices (LVADs) are artificial pumps used in end-stage heart failure to support the circulatory system. These cardiac assist devices work in parallel to the heart, diverting blood from the left ventricle through an outflow graft and into the ascending aorta. LVADs have allowed patients with end-stage heart failure to live longer and with improved quality of life compared to best medical therapy alone. However, they are associated with significant risks related to both thrombosis and bleeding in this medically complex patient population. As LVADs continue to be used more widely, stroke ne...
Source: Cerebrovascular Diseases - September 10, 2021 Category: Neurology Source Type: research
Editorial: Intracranial Bleeding After Reperfusion Therapy in Acute Ischemic Stroke
Source: Frontiers in Neurology - August 31, 2021 Category: Neurology Source Type: research
Mortality in patients with intracerebral haemorrhage associated with oral anticoagulation. Efficacy of a reversal protocol and clinical follow-up (ICH-OAC project)
CONCLUSIONS: ICH-OAC has a high mortality rate, related to the use of acenocoumarol and regardless of the initial clinical situation. A lower rate of early mortality was found among patients who received ART.PMID:34328205 | DOI:10.33588/rn.7305.2020565
Source: Revista de Neurologia - July 30, 2021 Category: Neurology Authors: P Amores-Valenciano E Ruiz Escribano-Taravilla C M Romero-S ánchez A Prado-Mira E Garc ía-Gil A B Espejo-L ópez R M Collado-Jim énez J D Molina-Nuevo A Mar ín-Sánchez F Hern ández-Fernández Source Type: research
